Aminoindanes--the next wave of 'legal highs'?

scientific article

Aminoindanes--the next wave of 'legal highs'? is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/DTA.318
P698PubMed publication ID21748859
P5875ResearchGate publication ID51485416

P2093author name stringR A Braithwaite
R P Archer
L A King
A T Kicman
P D Sainsbury
P2860cites workFatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)Q28139597
Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamineQ28256742
5-iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamineQ28268394
Bioanalysis of new designer drugsQ33748885
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).Q33996413
2-Aminoindans of pharmacological interestQ34218400
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potentialQ34461106
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analoguesQ34549018
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugsQ34645841
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).Q34997151
Reinforcing effects of certain serotonin-releasing amphetamine derivatives.Q52203594
Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.Q52298270
Cat and mouse: the analytical toxicology of designer drugsQ83409031
P433issue7-8
P304page(s)479-482
P577publication date2011-07-11
P1433published inDrug Testing and AnalysisQ3040088
P1476titleAminoindanes--the next wave of 'legal highs'?
P478volume3

Reverse relations

cites work (P2860)
Q48625700A brief history of 'new psychoactive substances'.
Q47869636Amide-Directed C-H Sodiation by a Sodium Hydride/Iodide Composite.
Q38510888An overview of recent developments in the analytical detection of new psychoactive substances (NPSs).
Q83354105Annual banned-substance review: analytical approaches in human sports drug testing
Q37663461Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals
Q28255977Impact of the emergence of designer drugs upon sports doping testing
Q42395888Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents
Q38123776MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update
Q38191529New phenethylamines in Europe
Q91020544The metabolic fate of two new psychoactive substances - 2-aminoindane and N-methyl-2-aminoindane - studied in vitro and in vivo to support drug testing
Q97887124Understanding the Contribution of Individual Amino Acid Residues in the Binding of Psychoactive Substances to Monoamine Transporters